Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects
NCT00439010
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Alzheimers Disease
Interventions
DRUG:
[123I] AV 39
Sponsor
Molecular NeuroImaging
Collaborators
[object Object]